Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianshui Niu

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Infection and Drug Resistance|May 8, 2018
A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible <i>Klebsiella pneumoniae</i> bloodstream infections: tigecycline significantly increases the mortalityTingting Xiao, Wei Yu, Tianshui Niu, et al.
BMC Infectious Diseases|November 8, 2019
The clinical features and prognosis of infective endocarditis in the elderly from 2007 to 2016 in a tertiary hospital in ChinaZhenzhu Wu, Yi Chen, Tingting Xiao, et al.
Infection and Drug Resistance|May 4, 2023
Prevalent Dominant <i>Acinetobacter baumannii</i> ST191/195/208 Strains in Bloodstream Infections Have High Drug Resistance and MortalityTianshui Niu, Lihua Guo, Xiaoyang Kong, et al.
Antimicrobial Resistance and Infection Control|March 20, 2019
Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant <i>Acinetobacter baumannii</i>Tianshui Niu, Qixia Luo, Yaqing Li, et al.
BMC Infectious Diseases|June 20, 2020
Epidemiology and risk factors of infective endocarditis in a tertiary hospital in China from 2007 to 2016Zhenzhu Wu, Yi Chen, Tingting Xiao, et al.
Gene|May 9, 2012
Microarray profiling of HepG2 cells ectopically expressing NDRG2Xuewu Liu, Tianshui Niu, Xingping Liu, et al.
Infection and Drug Resistance|February 3, 2018
Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> with in vitro pharmacokinetics/pharmacodynamics simulationChen Huang, Beiwen Zheng, Wei Yu, et al.
Virulence|December 28, 2019
<i>Wza</i> gene knockout decreases <i>Acinetobacter baumannii</i> virulence and affects Wzy-dependent capsular polysaccharide synthesisTianshui Niu, Lihua Guo, Qixia Luo, et al.
Frontiers in Cellular and Infection Microbiology|July 4, 2017
<i>In vitro</i> Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing <i>Klebsiella pneumoniae</i>Wei Yu, Kai Zhou, Lihua Guo, et al.
BMC Infectious Diseases|August 31, 2023
The epidemiological characteristics and infection risk factors for extrapulmonary tuberculosis in patients hospitalized with pulmonary tuberculosis infection in China from 2017 to 2021Tianshui Niu, Fei He, Jianshe Yang, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Infection and Drug Resistance|May 8, 2018
A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible <i>Klebsiella pneumoniae</i> bloodstream infections: tigecycline significantly increases the mortalityTingting Xiao, Wei Yu, Tianshui Niu, et al.
BMC Infectious Diseases|November 8, 2019
The clinical features and prognosis of infective endocarditis in the elderly from 2007 to 2016 in a tertiary hospital in ChinaZhenzhu Wu, Yi Chen, Tingting Xiao, et al.
Infection and Drug Resistance|May 4, 2023
Prevalent Dominant <i>Acinetobacter baumannii</i> ST191/195/208 Strains in Bloodstream Infections Have High Drug Resistance and MortalityTianshui Niu, Lihua Guo, Xiaoyang Kong, et al.
Antimicrobial Resistance and Infection Control|March 20, 2019
Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant <i>Acinetobacter baumannii</i>Tianshui Niu, Qixia Luo, Yaqing Li, et al.
BMC Infectious Diseases|June 20, 2020
Epidemiology and risk factors of infective endocarditis in a tertiary hospital in China from 2007 to 2016Zhenzhu Wu, Yi Chen, Tingting Xiao, et al.
Gene|May 9, 2012
Microarray profiling of HepG2 cells ectopically expressing NDRG2Xuewu Liu, Tianshui Niu, Xingping Liu, et al.
Infection and Drug Resistance|February 3, 2018
Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> with in vitro pharmacokinetics/pharmacodynamics simulationChen Huang, Beiwen Zheng, Wei Yu, et al.
Virulence|December 28, 2019
<i>Wza</i> gene knockout decreases <i>Acinetobacter baumannii</i> virulence and affects Wzy-dependent capsular polysaccharide synthesisTianshui Niu, Lihua Guo, Qixia Luo, et al.
Frontiers in Cellular and Infection Microbiology|July 4, 2017
<i>In vitro</i> Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing <i>Klebsiella pneumoniae</i>Wei Yu, Kai Zhou, Lihua Guo, et al.
BMC Infectious Diseases|August 31, 2023
The epidemiological characteristics and infection risk factors for extrapulmonary tuberculosis in patients hospitalized with pulmonary tuberculosis infection in China from 2017 to 2021Tianshui Niu, Fei He, Jianshe Yang, et al.
Pageof 2